Wall Street Analysts Predict a 250.59% Upside in Altimmune (ALT): Here's What You Should Know

Shares of Altimmune, Inc. (ALT) have gained 23.2% over the past four weeks to close the last trading session at $5.1, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $17.88 indicates a potential upside of 250.6%.The mean estimate comprises eight short-term price targets with a standard deviation of $8.81. While the lowest estimate of $1.00 indicates a 80.4% decline from the curr ...